Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Diabetic Nephropathy in Mice

Oral administration of resveratrol is able to ameliorate the progression of diabetic nephropathy (DN); however, its mechanisms of action remain unclear. Recent evidence suggested that the gut microbiota is involved in the metabolism therapeutics. In the current study, we sought to determine whether...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ting-Ting Cai, Xiao-Long Ye, Ru-Run Li, Hui Chen, Ya-Yun Wang, Hui-Juan Yong, Ming-Lin Pan, Wei Lu, Ying Tang, Heng Miao, Antoine M. Snijders, Jian-Hua Mao, Xing-Yin Liu, Yi-Bing Lu, Da-Fa Ding
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2020-08-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	diabetic nephropathy resveratrol gut microbiome inflammation gut–kidney axis
Accés en línia:	https://www.frontiersin.org/article/10.3389/fphar.2020.01249/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!